Voyageur Pharmaceuticals Ltd.
VYYRF
$0.08
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.25% | -102.10% | -99.32% | -62.45% | -57.66% |
| Total Depreciation and Amortization | -27.27% | -33.33% | -30.77% | -28.57% | -26.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.73% | 83.02% | 69.25% | 77.46% | 72.48% |
| Change in Net Operating Assets | 230.16% | -80.16% | -86.55% | -51.03% | 41.30% |
| Cash from Operations | -50.64% | -708.74% | -616.34% | -180.23% | -55.54% |
| Capital Expenditure | -48.66% | -59.28% | -27.74% | 9.23% | 2.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -48.66% | -59.28% | -27.74% | 9.23% | 2.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.32% | 570.19% | 567.63% | 234.63% | 216.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | 65.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -475.23% | -412.24% | -29.07% | 208.65% | 484.58% |
| Cash from Financing | -16.47% | 345.06% | 599.23% | 253.51% | 243.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -248.64% | -39.95% | 19,761.76% | 416.69% | 190.42% |